FDA inspection
Anika Therapeutics, Inc.: FDA inspection ending Jan 22, 2026
FDA inspection 1281778 · Voluntary Action Indicated (VAI) · Bedford, MA
Key facts
| Inspection ID | 1281778 |
|---|---|
| Firm | Anika Therapeutics, Inc. |
| FEI number | 3007093114 |
| Address | 32 Wiggins Ave |
| City | Bedford |
| State | MA |
| ZIP | 01730 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jan 22, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data